Sustained intraocular pressure elevation in eyes treated with intravitreal injections of anti-vascular endothelial growth factor for diabetic macular edema in a real-life setting

@article{Kim2017SustainedIP,
  title={Sustained intraocular pressure elevation in eyes treated with intravitreal injections of anti-vascular endothelial growth factor for diabetic macular edema in a real-life setting},
  author={S{\'e}tha Vo Kim and Franck Fajnkuchen and Val{\'e}rie Sarda and Lise Qu-Knafo and Bahram Bodaghi and Audrey Giocanti-Aur{\'e}gan},
  journal={Graefe's Archive for Clinical and Experimental Ophthalmology},
  year={2017},
  volume={255},
  pages={2165-2171}
}
PurposeThe aim of this study was to investigate the sustained intraocular pressure (IOP) elevation after repeated anti-VEGF intravitreal injections (IVI) in patients with diabetic macular edema (DME).MethodsA retrospective study included 140 eyes without prior glaucoma, treated with at least three anti-VEGF injections for DME between 2012 and 2016. IOP elevation was defined by an increase above baseline IOP by ≥6 mmHg. Baseline IOP was defined as the mean of IOP values before treatment… CONTINUE READING

Citations

Publications citing this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 44 REFERENCES

proposed pathophysiology due to altered nitric oxide metabolism

AM Ricca, RG Morshedi, therapy Wirostko BM High intraocular pressure following an factor
  • J Ocul Pharmacol Ther Off J Assoc Ocul Pharmacol Ther 31:2–10. https://doi.org/10.1089/jop.2014.0062 Graefes Arch Clin Exp Ophthalmol
  • 2017
VIEW 1 EXCERPT